SU1709999A1 - Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss - Google Patents

Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss Download PDF

Info

Publication number
SU1709999A1
SU1709999A1 SU894767363A SU4767363A SU1709999A1 SU 1709999 A1 SU1709999 A1 SU 1709999A1 SU 894767363 A SU894767363 A SU 894767363A SU 4767363 A SU4767363 A SU 4767363A SU 1709999 A1 SU1709999 A1 SU 1709999A1
Authority
SU
USSR - Soviet Union
Prior art keywords
thresholds
determining
hearing loss
effectiveness
neuro
Prior art date
Application number
SU894767363A
Other languages
Russian (ru)
Inventor
Александр Семенович Розенблюм
Виктор Иванович Пудов
Ефим Михайлович Цирульников
Максим Станиславович Шатилов
Владимир Иванович Линьков
Original Assignee
Ленинградский Научно-Исследовательский Институт Уха, Горла, Носа И Речи
Институт Эволюционной Физиологии И Биохимии Им.И.М.Сеченова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ленинградский Научно-Исследовательский Институт Уха, Горла, Носа И Речи, Институт Эволюционной Физиологии И Биохимии Им.И.М.Сеченова filed Critical Ленинградский Научно-Исследовательский Институт Уха, Горла, Носа И Речи
Priority to SU894767363A priority Critical patent/SU1709999A1/en
Application granted granted Critical
Publication of SU1709999A1 publication Critical patent/SU1709999A1/en

Links

Abstract

Изобретение относитс  к медицине, а именно к отоларингологии^и позвол ет повысить точность определени  эффективности консервативного лечени  нейрпэсенсорной тугоухости. Это достигаетс  регистрацией тональной аудиограммы, определением порогов по воздушной проводимости и при воздействии ультразвуковыми колебани ми мегагерцевого диапазона, модулированными по амплитуде синусоидальными сигналами, соответствующими аудиометрическими частотами 125- 8000 Гц, и при наличии более ни;зких порогов дл  модулированного ультразвука не менее чем на 10 дБ на трех и более частотах определ ют эффективность консервативного лечени .^^ ч*» •^Изобретение относитс  к медицине/а именно к отоларингологии.Цель изобретени  - повышение точности определени .Способ осуществл ют следующим образом.У больного с помощью стандартного аудиометра определ ют слуховые пороги по воздушной проводимости. Затем определ ют пороги слышимости, воздейству  ультразвуковыми колебани ми из мегагерцевого диапазона частот The invention relates to medicine, in particular, to otolaryngology, and allows to improve the accuracy of determining the effectiveness of conservative treatment of neural sensory hearing loss. This is achieved by recording a tone audiogram, determining the thresholds for air conduction and when exposed to ultrasonic vibrations of the megahertz range, amplitude modulated sinusoidal signals corresponding to audiometric frequencies of 125-8000 Hz, and if there are more low thresholds for modulated ultrasound by at least 10 dB at three or more frequencies determine the effectiveness of conservative treatment. ^^ h * "• ^ The invention relates to medicine / namely to otolaryngology. The purpose of the invention is to improve The accuracy of the determination is as follows. The method is carried out as follows. The patient’s auditory thresholds for air conduction are determined using a standard audiometer. Then, hearing thresholds are determined by ultrasonic vibrations from the megahertz frequency range.

Description

направлении фокальной области в ушной лабиринт на тех же аудиометрических частотах модул ции (125-8000 Гц). Ультразвукова  частотно-порогова  крива  на аудйометрическом бланке располагаетс  на уровне 10-15 дБ. Разрыв между звуковыми и ультразвуковыми порогами составл ет бО-ТО дБ, у больной имеетс  хороший положительный прогноз дл  медикаментозного лечени , в то врем  как по прототипу прогноз лечени  неблагопри тный из-за большой степени тугоухости. Через 12 дней лечени  антигипоксантами у больной слух восстановилс  практически до исходного уровн . Величина прироста слуха составила 60-70 дБ.the direction of the focal area in the ear maze at the same audiometric modulation frequencies (125-8000 Hz). The ultrasonic frequency threshold curve on the audiometric form is located at a level of 10-15 dB. The gap between the sonic and ultrasonic thresholds is B-TO dB, the patient has a good positive prognosis for drug treatment, while the prototype of the treatment prognosis is unfavorable due to the high degree of hearing loss. After 12 days of treatment with antihypoxants, the patient's hearing was restored to almost the original level. The magnitude of the increase in hearing was 60-70 dB.

Claims (1)

Формула изобретени   Способ определени  эффективности консервативного лечени  нейросенсорной тугоухости путем регистрации тональной аудиограммы и определени  порогов слуховой чувствительности, отличающийс  тем, что. с целью повышени  точности определени , дополнительно регистрируют тональную аудиограмму на фоне стимул ции уха ультразвуковом мегагерцевого диапазона , модулиррванным по амплитуде синусоидальными сигналами, соответствующими аудиометрическими частотами 125-8000 Гц, и при снижении порогов слуховой чувствительности не менее чем на 10 дБ на трех и более частотах лечение определ ют аффективным.Claims The method of determining the effectiveness of conservative treatment of sensorineural hearing loss by recording a tone audiogram and determining the thresholds of auditory sensitivity, characterized in that. in order to improve the accuracy of determination, a tone audiogram is additionally recorded against the background of stimulation of the ear of the megahertz ultrasonic range modulated in amplitude with sinusoidal signals corresponding to audiometric frequencies of 125-8000 Hz, and with a decrease in hearing sensitivity thresholds of at least 10 dB at three or more treatment is defined as affective.
SU894767363A 1989-12-06 1989-12-06 Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss SU1709999A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU894767363A SU1709999A1 (en) 1989-12-06 1989-12-06 Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU894767363A SU1709999A1 (en) 1989-12-06 1989-12-06 Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss

Publications (1)

Publication Number Publication Date
SU1709999A1 true SU1709999A1 (en) 1992-02-07

Family

ID=21483773

Family Applications (1)

Application Number Title Priority Date Filing Date
SU894767363A SU1709999A1 (en) 1989-12-06 1989-12-06 Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss

Country Status (1)

Country Link
SU (1) SU1709999A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009572A1 (en) * 1993-10-04 1995-04-13 Baxter International Inc. Ultrasound catheter system having modulated output with feedback control

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Frledrich G.. Wolf G., Prognostisch relevante Faktoren beim Horsturz, HNO, 1984, Bd. 32, 2, s. 74-79. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009572A1 (en) * 1993-10-04 1995-04-13 Baxter International Inc. Ultrasound catheter system having modulated output with feedback control

Similar Documents

Publication Publication Date Title
McCormick et al. Sound conduction in the dolphin ear
Dunn Temperature and amplitude dependence of acoustic absorption in tissue
LEMPERT et al. The cochleogram and its clinical application: a preliminary report
Lenhardt et al. Measurement of bone conduction levels for high frequencies
US7457741B2 (en) Device for transmitting speech information
Tsirulnikov et al. Use of amplitude-modulated focused ultrasound for diagnosis of hearing disorders
US4784115A (en) Anti-stuttering device and method
Strother The electrical response of the auditory mechanism in the bullfrog (Rana catesbeiana).
Tonndorf et al. Some properties of sound transmission in the middle and outer ears of cats
SU1709999A1 (en) Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss
Dallos et al. Even‐Order Subharmonics in the Peripheral Auditory System
Pang et al. Growth rate of simultaneous masking in cat auditory-nerve fibers: Relationship to the growth of basilar-membrane motion and the origin of two-tone suppression
Canlon Protection against noise trauma by sound conditioning
Abramovich Auditory perception of ultrasound in patients with sensorineural and conductive hearing loss
Dishoeck The continuous threshold or detailed audiogram for recording stimulation deafness
Tonndorf et al. The occlusion of the external ear canal: its effect upon bone conduction in cats
Katzke et al. Suction-generated noise in the external meatus and sensorineural hearing loss
König On the use of hearing-aid type earphones in clinical audiometry
Rasmy Stapedius reflex after stapedectomy with preservation of the stapedius tendon
SALTZMAN et al. Masking and shadow hearing in bone conduction
Nomura et al. Dynamic tympanometry
Jerger et al. Suprathreshold abnormalities of the stapedius reflex in acoustic tumor: a series of case reports
Lowy Experiments on the Pellet‐Type of Artificial Drum
Gcrull et al. Low-frequency masking of brainstem potentials
Gelfand et al. Temporal Summation in Acoustic Reflex Growth Functions S